EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 166 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,551,216 | -9.7% | 98,365 | +11.3% | 0.00% | 0.0% |
| Q2 2023 | $1,718,690 | -7.4% | 88,410 | +32.8% | 0.00% | 0.0% |
| Q1 2023 | $1,856,752 | +184.1% | 66,598 | +197.9% | 0.00% | 0.0% |
| Q4 2022 | $653,495 | +166.7% | 22,357 | +365.5% | 0.00% | – |
| Q4 2021 | $245,000 | -40.7% | 4,803 | -35.1% | 0.00% | – |
| Q3 2021 | $413,000 | -27.7% | 7,402 | -39.7% | 0.00% | – |
| Q4 2020 | $571,000 | +9.8% | 12,267 | +0.3% | 0.00% | – |
| Q3 2020 | $520,000 | -27.4% | 12,231 | -18.0% | 0.00% | -100.0% |
| Q2 2020 | $716,000 | -43.2% | 14,924 | -45.5% | 0.00% | -50.0% |
| Q1 2020 | $1,260,000 | -10.1% | 27,388 | +17.4% | 0.00% | +100.0% |
| Q4 2019 | $1,402,000 | -54.7% | 23,336 | -57.3% | 0.00% | -66.7% |
| Q3 2019 | $3,092,000 | +2.7% | 54,660 | +1.0% | 0.00% | 0.0% |
| Q2 2019 | $3,012,000 | +1250.7% | 54,093 | +1582.5% | 0.00% | – |
| Q3 2018 | $223,000 | -88.4% | 3,215 | -88.3% | 0.00% | -100.0% |
| Q3 2016 | $1,920,000 | -56.9% | 27,425 | -76.1% | 0.00% | -60.0% |
| Q2 2016 | $4,457,000 | +1.6% | 114,901 | +6.1% | 0.01% | 0.0% |
| Q1 2016 | $4,388,000 | -59.3% | 108,334 | -10.9% | 0.01% | -61.5% |
| Q4 2015 | $10,775,000 | +121.6% | 121,520 | +85.0% | 0.01% | +116.7% |
| Q3 2015 | $4,862,000 | – | 65,678 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |